CRSP vs KYMR
CRISPR Therapeutics AG · Kymera Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | CRSP | KYMR |
|---|---|---|
| Price | $55.79 | $117.39 |
| Market Cap | $5.39B | $9.76B |
| P/E | — | — |
| P/B | 3.09 | 6.47 |
| P/S | 1536.89 | 248.94 |
| ROE | -33.3% | -20.6% |
| Net Margin | -16569.8% | -794.0% |
| Gross Margin | — | — |
| Revenue Growth | -90.6% | -16.7% |
| Dividend Yield | — | — |
| EPS | -$6.01 | -$3.74 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.